Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × COVID-19 × CVnCoV COVID-19 vaccine × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1 COVID-19 1

Interventions

tocilizumab 1 selinexor 1 lenzilumab 1 cilgavimab and tixagevimab drug combination 1 Standard of Care 1 Practice Guidelines as Topic 1 Observation 1 Interferon-alpha 1 Immunoglobulin G 1 IMM-101 1 Disulfides 1 CVnCoV COVID-19 vaccine 1 COVID-19 Vaccines 1 BNT162 Vaccine 1 2019-nCoV Vaccine mRNA-1273 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04951323 2022-05-18

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

University of Liege

Phase 3 Unknown

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡